Evidence map›Paper›PMID 42866569›Full record

ArticleJHLT open2026

Right ventricular remodeling after veno-venous extracorporeal membrane oxygenation bridge to lung transplantation in adults with severe lung disease.

Christian O'Donnell, Bettia Celestin, Jose Rios-Monterrosa, Giovanni Perottino, Hee Do Jeon, Katherine E Kent, Louise Y Sun, Kiran K Khush, Francois Haddad, Melissa A Vogelsong

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in JHLT open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Christian O'DonnellDivision of Cardiothoracic Anesthesiology, Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine, Stanford, California.
Bettia CelestinDivision of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, California.
Jose Rios-MonterrosaDepartment of Anesthesiology, Perioperative, and Pain Medicine, Stanford University School of Medicine, Stanford, California.
Giovanni PerottinoDepartment of Anesthesiology, Perioperative, and Pain Medicine, Stanford University School of Medicine, Stanford, California.
Hee Do JeonDivision of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, California.
Katherine E KentDepartment of Anesthesiology, Perioperative, and Pain Medicine, Stanford University School of Medicine, Stanford, California.
Louise Y SunDivision of Cardiothoracic Anesthesiology, Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine, Stanford, California.
Kiran K KhushDivision of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, California.
Francois HaddadDivision of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, California.
Melissa A VogelsongDivision of Cardiothoracic Anesthesiology, Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine, Stanford, California.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Right ventricular (RV) dysfunction is a common complication of advanced lung disease, yet data on RV remodeling and long-term outcomes following veno-venous extracorporeal membrane oxygenation (VV-ECMO) as a bridge to lung transplantation remain limited. Methods: We conducted a retrospective cohort study of consecutive adult patients bridged to lung transplant on VV-ECMO from January 1, 2015, to December 31, 2022. Transthoracic echocardiograms were analyzed pre-transplant (on VV-ECMO) and post-transplant in the "early" ( Results: Twenty patients were included (65.0% male, median age 47.5 [IQR: 41.5-56.4]) with primary etiologies of interstitial lung disease (50.0%) and COVID-19 (30.0%). In the "early" post-transplant phase, median RV systolic pressure decreased from 70.0 to 31.2 mm Hg ( Conclusions: Meaningful RV recovery and favorable 3-year survival appear achievable after VV-ECMO bridge to transplantation, even among patients with moderate-to-severe pre-transplant RV dysfunction.

Indexed as

echocardiographyextracorporeal membrane oxygenation (ECMO)lung transplantationright ventricleRV remodeling

Identifiers

PMID42866569
PMCPMC13656967

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.